 | Up a level |
Gencer, Baris; Eisen, Alon; Berger, David; Nordio, Francesco; Murphy, Sabina A; Grip, Laura T; Chen, Cathy; Lanz, Hans; Ruff, Christian T; Antman, Elliott M; Braunwald, Eugene; Giugliano, Robert P (2022). Edoxaban vs. Warfarin in High-risk Patients with Atrial Fibrillation: A Comprehensive Analysis of High-Risk Subgroups. American Heart Journal, 247, pp. 24-32. Elsevier 10.1016/j.ahj.2021.12.017
Van Mieghem, Nicolas M; Unverdorben, Martin; Hengstenberg, Christian; Möllmann, Helge; Mehran, Roxana; López-Otero, Diego; Nombela-Franco, Luis; Moreno, Raul; Nordbeck, Peter; Thiele, Holger; Lang, Irene; Zamorano, José L; Shawl, Fayaz; Yamamoto, Masanori; Watanabe, Yusuke; Hayashida, Kentaro; Hambrecht, Rainer; Meincke, Felix; Vranckx, Pascal; Jin, James; ... (2021). Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR. The New England journal of medicine, 385(23), pp. 2150-2160. Massachusetts Medical Society 10.1056/NEJMoa2111016
